BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernando DH, Forbes JM, Angus PW, Herath CB. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. Int J Mol Sci. 2019;20. [PMID: 31614491 DOI: 10.3390/ijms20205037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Yuan X, Nie C, Liu H, Ma Q, Peng B, Zhang M, Chen Z, Li J. Comparison of metabolic fate, target organs, and microbiota interactions of free and bound dietary advanced glycation end products. Crit Rev Food Sci Nutr 2021;:1-22. [PMID: 34698575 DOI: 10.1080/10408398.2021.1991265] [Reference Citation Analysis]
2 Litwinowicz K, Waszczuk E, Gamian A. Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis. Nutrients 2021;13:3370. [PMID: 34684371 DOI: 10.3390/nu13103370] [Reference Citation Analysis]
3 Mayén AL, Aglago EK, Knaze V, Cordova R, Schalkwijk CG, Wagner KH, Aleksandrova K, Fedirko V, Keski-Rahkonen P, Leitzmann MF, Katzke V, Srour B, Schulze MB, Masala G, Krogh V, Panico S, Tumino R, Bueno-de-Mesquita B, Brustad M, Agudo A, Chirlaque López MD, Amiano P, Ohlsson B, Ramne S, Aune D, Weiderpass E, Jenab M, Freisling H. Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. Int J Cancer 2021. [PMID: 33899229 DOI: 10.1002/ijc.33612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Segura-Azuara NLÁ, Varela-Chinchilla CD, Trinidad-Calderón PA. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Front Med (Lausanne) 2021;8:774079. [PMID: 35096868 DOI: 10.3389/fmed.2021.774079] [Reference Citation Analysis]
5 van Dongen KCW, Linkens AMA, Wetzels SMW, Wouters K, Vanmierlo T, van de Waarenburg MPH, Scheijen JLJM, de Vos WM, Belzer C, Schalkwijk CG. Dietary advanced glycation endproducts (AGEs) increase their concentration in plasma and tissues, result in inflammation and modulate gut microbial composition in mice; evidence for reversibility. Food Res Int 2021;147:110547. [PMID: 34399524 DOI: 10.1016/j.foodres.2021.110547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Han JH, Park MH, Myung CS. Garcinia cambogia Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation. Antioxidants (Basel) 2021;10:1226. [PMID: 34439474 DOI: 10.3390/antiox10081226] [Reference Citation Analysis]
7 Rungratanawanich W, Qu Y, Wang X, Essa MM, Song BJ. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med 2021;53:168-88. [PMID: 33568752 DOI: 10.1038/s12276-021-00561-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
8 Zhao YW, Yang J, Niu J, Wang T, Liang XD, Ren Y, Wang R. Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation. Evid Based Complement Alternat Med 2021;2021:3364579. [PMID: 34887931 DOI: 10.1155/2021/3364579] [Reference Citation Analysis]
9 Petriv N, Neubert L, Vatashchuk M, Timrott K, Suo H, Hochnadel I, Huber R, Petzold C, Hrushchenko A, Yatsenko AS, Shcherbata HR, Wedemeyer H, Lichtinghagen R, Falfushynska H, Lushchak V, Manns MP, Bantel H, Semchyshyn H, Yevsa T. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer. Oncoimmunology 2021;10:1874159. [PMID: 33628620 DOI: 10.1080/2162402X.2021.1874159] [Reference Citation Analysis]
10 Pereira ENGDS, Paula DP, Araujo BP, Fonseca MJMD, Diniz MFHS, Daliry A, Griep RH. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World J Gastroenterol 2021; 27(29): 4913-4928 [PMID: 34447235 DOI: 10.3748/wjg.v27.i29.4913] [Reference Citation Analysis]
11 Simón J, Delgado TC, Martinez-Cruz LA, Martínez-Chantar ML. Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities. Biomedicines 2021;9:125. [PMID: 33513920 DOI: 10.3390/biomedicines9020125] [Reference Citation Analysis]
12 Venter C, Pickett K, Starling A, Maslin K, Smith PK, Palumbo MP, O'Mahony L, Ben Abdallah M, Dabelea D. Advanced glycation end product intake during pregnancy and offspring allergy outcomes: A Prospective cohort study. Clin Exp Allergy 2021;51:1459-70. [PMID: 34610188 DOI: 10.1111/cea.14027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Luketin M, Mizdrak M, Boric-Skaro D, Martinovic D, Tokic D, Vilovic M, Supe-Domic D, Ticinovic Kurir T, Bozic J. Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis. Biomolecules 2021;11:456. [PMID: 33803864 DOI: 10.3390/biom11030456] [Reference Citation Analysis]
14 Alshanwani AR, Hagar H, Shaheen S, Alhusaini AM, Arafah MM, Faddah LM, Alharbi FM, Sharma AK, Badr AM. A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases. Eur J Pharmacol 2022;:174910. [PMID: 35339478 DOI: 10.1016/j.ejphar.2022.174910] [Reference Citation Analysis]
15 Bárcena B, Salamanca A, Pintado C, Mazuecos L, Villar M, Moltó E, Bonzón-Kulichenko E, Vázquez J, Andrés A, Gallardo N. Aging Induces Hepatic Oxidative Stress and Nuclear Proteomic Remodeling in Liver from Wistar Rats. Antioxidants (Basel) 2021;10:1535. [PMID: 34679670 DOI: 10.3390/antiox10101535] [Reference Citation Analysis]
16 Li Y, Yang X, Plummer R, Hayashi Y, Deng XS, Nie YZ, Taniguchi H. Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy. Int J Mol Sci 2021;22:10471. [PMID: 34638810 DOI: 10.3390/ijms221910471] [Reference Citation Analysis]
17 Papadopoulos C, Tentes I, Anagnostopoulos K. Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms. Maedica (Bucur) 2020;15:513-6. [PMID: 33603909 DOI: 10.26574/maedica.2020.15.4.513] [Reference Citation Analysis]
18 Gao LL, Ma JM, Fan YN, Zhang YN, Ge R, Tao XJ, Zhang MW, Gao QH, Yang JJ. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. Int J Biol Macromol 2021;183:1379-92. [PMID: 33992651 DOI: 10.1016/j.ijbiomac.2021.05.066] [Reference Citation Analysis]
19 Kong W, Lyu C, Liao H, Du Y. Collagen crosslinking: effect on structure, mechanics and fibrosis progression. Biomed Mater 2021;16. [PMID: 34587604 DOI: 10.1088/1748-605X/ac2b79] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Rajapaksha IG, Gunarathne LS, Asadi K, Laybutt R, Andrikopoulous S, Alexander IE, Watt MJ, Angus PW, Herath CB. Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. Hepatology Communications. [DOI: 10.1002/hep4.1884] [Reference Citation Analysis]
21 Bingül İ, Aydın AF, Küçükgergin C, Doğan-Ekici I, Doğru-Abbasoğlu S, Uysal M. The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease. Turk J Med Sci 2021;51:1500-11. [PMID: 33421970 DOI: 10.3906/sag-2007-289] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chávez-rodríguez L, Escobedo-calvario A, Salas-silva S, Miranda-labra RU, Bucio L, Souza V, Gutiérrez-ruiz MC, Gomez-quiroz LE. Fructose Consumption and Hepatocellular Carcinoma Promotion. Livers 2021;1:250-62. [DOI: 10.3390/livers1040020] [Reference Citation Analysis]
23 Tahara N, Tahara A, Maeda-Ogata S, Yoshimura H, Bekki M, Sugiyama Y, Honda A, Igata S, Nishino Y, Matsui T, Fukami A, Enomoto M, Adachi H, Fukumoto Y, Yamagishi SI. Increased Urinary Levels of Pentosidine Measured by a Newly Developed Enzyme-Linked Immunosorbent Assay Are Independently Correlated with Fracture After Fall. Rejuvenation Res 2021;24:449-55. [PMID: 34846174 DOI: 10.1089/rej.2021.0066] [Reference Citation Analysis]
24 Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Med Sci (Basel) 2021;9:39. [PMID: 34205986 DOI: 10.3390/medsci9020039] [Reference Citation Analysis]
25 Sakasai-Sakai A, Takata T, Takeuchi M. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells. Int J Mol Sci 2020;21:E4861. [PMID: 32660150 DOI: 10.3390/ijms21144861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Armandi A, Schattenberg JM. Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches. Nutrients 2021;13:1977. [PMID: 34201382 DOI: 10.3390/nu13061977] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Li T, Zhang T, Cui T, Yang Y, Liu R, Chen Y, Yin C. Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome. J Steroid Biochem Mol Biol 2020;204:105752. [PMID: 32991990 DOI: 10.1016/j.jsbmb.2020.105752] [Reference Citation Analysis]
28 Tan J, Zhang J, Zhao Z, Zhang J, Dong M, Ma X, Liu S, Xin Y. The association between SNPs rs1800591 and rs3816873 of the MTTP gene and nonalcoholic fatty liver disease: A meta-analysis. Saudi J Gastroenterol 2020. [PMID: 32719241 DOI: 10.4103/sjg.SJG_201_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Priken K, Tapia G, Cadagan C, Quezada N, Torres J, D'espessailles A, Pettinelli P. Higher hepatic advanced glycation end products and liver damage markers are associated with non-alcoholic steatohepatitis. Nutrition Research 2022. [DOI: 10.1016/j.nutres.2022.04.005] [Reference Citation Analysis]